Filed: 5/14/2026ACC: 0001053906-26-000006
📋 What this filing means
ARTAL GROUP S.A. filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $1.01B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$1.01B
Total AUM (reported)
164.24M
Total Shares
Allocation by class
COM$769.20M76.1%
COM NEW$241.39M23.9%
Portfolio Concentration
Top 3$1.01B100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 164.24M
Sole
Full voting authority
164.24M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other2
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
Cava Group Inc
DFNDShares9.51M
TypeSH
Market value$769.20M
76.11%
Sole
9.51M
Shared
0.00
None
0.00
Lexicon Pharmaceuticals Inc
DFNDShares154.73M
TypeSH
Market value$241.39M
23.89%
Sole
154.73M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Cava Group IncDFND | COM | 9.51M | SH | $769.20M 76.11% | 9.51M | 0.00 | 0.00 |
Lexicon Pharmaceuticals IncDFND | COM NEW | 154.73M | SH | $241.39M 23.89% | 154.73M | 0.00 | 0.00 |